The role of osteoactivin-derived peptides in osteoblast differentiation

Medical Science Monitor

Volumn 13, Issue 12, 2007, Pages

  Selim, Abdulhafez A ^a   Castaneda, Julian L ^b   Owen, Thomas A ^c   Popoff, Steven N ^b   Safadi, Fayez F ^b  

^a KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS   (Saudi Arabia)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PFIZER INC   (United States)

Author keywords

Casien kinase II; Osteoactivin derived peptides; Osteoblast differentiation; RGD domain

Indexed keywords

ASPARTIC ACID; CASEIN KINASE II; GLUTAMIC ACID; MEMBRANE PROTEIN; OSTEOACTIVIN; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOBLAST; PROTEIN PHOSPHORYLATION;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM; CELL DIFFERENTIATION; CELL LINE; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; OSTEOBLASTS; OSTEOCALCIN; PEPTIDES;

EID: 37249034626     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Marks SC Jr, Popoff SN: Osteoclast biology in the osteopetrotic (op) rat. Am J Anat, 1989; 186: 325-34
2. Safadi FF, Xu J, Smock SL et al: Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts. J Cell Biochem, 2001; 84: 12-26
3. Hadjiargyrou M, Lombardo F, Zhao S et al: Transcriptional profiling of bone regeneration. Insight into the molecular complexity of wound repair. J Biol Chem, 2002; 277: 30177-82
4. Abe H, Uto H, Takami Y et al: Transgenic expression of osteoactivin in the liver attenuates hepatic fibrosis in rats. Biochem Biophys Res Commun, 2007; 11; 356(3): 610-15
5. Ogawa T, Nikawa T, Furochi H et al: Osteoactivin upregulates expression of MMP-3 and MMP-9 in fibroblasts infiltrated into denervated skeletal muscle in mice. Am J Physiol Cell Physiol, 2005; 289(3): C697-707
6. Selim AA, Abdelmagid SM, Kanaan RA et al: Anti-osteoactivin antibody inhibits osteoblast differentiation and function in vitro. Crit Rev Eukaryot Gene Expr, 2003; 13(2-4): 265-75
7. Ruoslahti E: RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol, 1996; (12): 697-715
8. Clark EA, Brugge JS: Integrins and signal transduction pathways: the road taken. Science, 1995; 268: 233-39
9. Schwartz MA, Schaller MD, Ginsberg MH: Integrins: emerging paradigms of signal transduction. Annu Rev Cell Dev Biol, 1995; 11: 549-99
10. Moursi AM, Globus RK, Damsky CH: Interactions between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro. J. Cell Sci, 1997; 110 (Pt 18): 2187-96
11. Takeuchi Y, Suzawa M, Kikuchi T et al: Differentiation and transforming growth factor-beta receptor down-regulation by collagen-alpha-2beta1 integrin interaction is mediated by focal adhesion kinase and its downstream signals in murine osteoblastic cells. J Biol Chem, 1997; 272: 29309-16
12. Damsky CH: Extracellular matrix-integrin interactions in osteoblast function and tissue remodeling. Bone, 1999; 25: 95-96
13. Franceschi RT, Iyer BS: Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J Bone Miner Res, 1992; (2): 235-46
14. Persson B: Bioinformatics in protein analysis. EXS, 2000; 88: 215-31
15. Mizejewski GJ: Peptides as receptor ligand drugs and their relationship to G-coupled signal transduction. Expert Opin Investig Drugs, 2001; 10(6): 1063-73
16. Marin O, Meggio F, Sarno S et al: Phosphorylation of synthetic fragments of inhibitor-2 of protein phosphatase-1 by casein kinase-1 and -2. Evidence that phosphorylated residues are not strictly required for efficient targeting by casein kinase-1. Eur J Biochem, 1994; 223(2): 647-53
17. Cornish J, Callon KE, Lin CQ et al: Dissociation of the effects of amylin on osteoblast proliferation and bone resorption. Am J Physiol, 1998; 274(5): E827-33
18. Shimizu N, Guo J, Gardella TJ: Parathyroid hormone (PTH)-(1-14) and -(1-11) analogs conformationally constrained by alpha-aminoisobutyric acid mediate full agonist responses via the juxtamembrane region of the PTH-1 receptor. J Biol Chem, 2001; 276(52): 4903-12
19. Owen TA, Aronow M, Shalhoub V et al: Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol, 1990; 143: 420-30
20. Hautanen A, Gailit J, Mann D, Ruoslahti E: Effects of modifications of the RGD sequence and its context on recognition by the fibronectin receptor. J Biol Chem, 1998; 264(3): 1437-42
21. Rehm BH: Bioinformatic tools for DNA/protein sequence analysis, functional assignment of genes and protein classification. Appl Microbiol Biotechnol, 2001; 57(5-6): 579-92
22. Sickmann A, Meyer HE: Phosphoamino acid analysis. Proteomics, 2001; 1(2): 200-6
23. Meggio F, Pinna LA: One-thousand-and-one substrates of protein kinase CK2? FASEB J, 2003; 17(3): 349-68
24. Salih E, Ashkar S, Gerstenfeld LC, Glimcher MJ: Protein kinases of cultured osteoblasts: selectivity for the extracellular matrix proteins of bone and their catalytic competence for osteopontin. J Bone Miner Res, 1996; 11(10): 1461-73
25. Seger D, Gechtman Z, Shaltiel S: Phosphorylation of vitronectin by casein kinase II. Identification of the sites and their promotion of cell adhesion and spreading. J Biol Chem, 1998; 273(38): 24805-13
26. Li R, Hoess RH, Bennett JS, DeGrado WF: Use of phage display to probe the evolution of binding specificity and affinity in integrins. Protein Eng, 2003; 16(1): 65-72
27. Alberts B, Johnson A, Lewis J et al: Molecular Biology of The Cell, 4th ed, 2002; 159
28. Andrade MA, Sander C: Bioinformatics: from genome data to biological knowledge. Curr. Opin. Biotechnol, 1997; 8(6): 675-83
29. Suzuki Y, Kubota T, Koizumi T et al: Extracellular processing of bone and dentin proteins in matrix mineralization. Connect, Tissue Res, 1996; 35(1-4): 223-39
30. Sfeir C, Veis A: The membrane associated kinases which phosphorylate bone and dentin extracellular matrix phosphoproteins are isoforms of cytosolic CKII. Connect Tissue Res, 1996; 35(1-4): 215-22
31. Rifas L, Cheng S, Halstead LR et al: Skeletal casein kinase activity defect in the HYP mouse. Calcif Tissue Int, 1997; 61(3): 256-59
32. Body JJ: Management of primary osteoporosis. Acta Clin Belg, 2002; 57(5): 277-83
33. Jilka RL: Biology of the basic multicellular unit and the pathophysiology of osteoporosis. Med Pediatr Oncol, 2003; 41(3): 182-85
34. Bab IA, Einhorn TA: Regulatory role of osteogenic growth polypeptides in bone formation and hemopoiesis. Crit Rev Eukaryot Gene Expr, 1993; 3(1): 31-46
35. Whitfield JF, Morley P, Willick GE: The parathyroid hormones: bone-forming agents for treatment of osteoporosis. Medscape. Womens Health, 2000; 5(5): E5
36. Chen YC, Muhlrad A, Shteyer A et al: Bioactive pseudopeptidic analogues and cyclostereoisomers of osteogenic growth peptide C-terminal pentapeptide, OGP(10-14). J Med Chem, 2002; 45(8): 1624-32